COST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTION
Yeongin Jung, Kaili Wu, Mashael Alnufeay, Xiaotong Jin, Jeromie Ballreich, Emmanuel Drabo · 2024
Read COST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTION by Yeongin Jung, Kaili Wu, Mashael Alnufeay, Xiaotong Jin, Jeromie Ballreich, Emmanuel Drabo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11691907.txt.
Description
Yeongin Jung and co-authors present a 2024 study on the cost-effectiveness of screening older adults for early Alzheimer disease. New drugs that slow the disease and a sharp blood test have made early detection practical. The team compared two plans for adults aged 65 and over with early brain changes.
One plan uses the blood test alone. The other follows a positive blood test with a brain scan to confirm. A model joining a decision tree with a long-term disease model simulated one thousand people. Costs and health gains were tracked for each plan. The study helps health systems judge which screening path gives fair value.
Catalog record
| CREATOR | Yeongin Jung, Kaili Wu, Mashael Alnufeay, Xiaotong Jin, Jeromie Ballreich, Emmanuel Drabo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |